Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AICAR for Lesch-Nyhan Disease
NCT00004314Phase 2Completed
- Sponsor
- National Center for Research Resources
- Start
- Feb 1996
- Modality
- Small Molecules
01
Overview
Phase 2, open-label, single-arm trial of acadesine in Lesch-Nyhan syndrome (LNS), sponsored by National Center for Research Resources. Primary endpoint: Effects of AICAR on hematologic manifestations at 12 days. Started Feb 1996; status: completed.
02
Drugs
acadesine
03
Conditions
Lesch-Nyhan syndrome (LNS)
Beyond the preview
Go deeper on NCT00004314.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004314.